Study identifier:NIS-CKR-CRE-2007/6
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An observational, non-interventional, multi-center study to evaluate efficacy and tolerability of high dose rosuvastatin in High Risk Patients after titration
Hypercholesterolemia
-
No
-
All
1482
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|